BoniAncol
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80086543
- Status
- Active licence
- Licence date
- 25 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 300 milligramme | Not calculated |
| Piper methysticum Source : Rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 200 milligramme Potency : 10 % Kavalactones | 10 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 10 milligramme | 20,000 µg |
Non-medicinal ingredients
Dioxyde de titane, Silice pyrogénée, Stéarate de magnésium, Gélatine, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Provides antioxidants. Source of vitamin/mineral, factors in the maintenance of good health. Helps the body to metabolize carbohydrates, proteins, and fats. Helps in tissue formation. Helps in the development and maintenance of bones and teeth. Helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are taking antibiotics, do not use this product. If you are taking nitroglycerin, do not use this product. Do not use if you have liver and kidney disorders. Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
If you have kidney stones, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. Consult a health care practitioner prior to use if you are taking any medication. Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol is not recommended. Excessive use, or use with products that cause drowsiness, may impair your ability to operate a vehicle or heavy machinery.
- Effets indésirables connus
Hypersensitivity is known to occur, in which case discontinue use. Discontinue use and consult a health care practitioner if abdominal pain, fever, vomiting, dark urine, yellow eyes or skin. Gastrointestinal discomfort may occur, in which case discontinue use.
Source
Official Health Canada record, licence 80086543
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.